EUCTR2016-001967-35-AT进行中（未招募）1 期
A double-blind, placebo-controlled cross-over study to assess the efficacy of topical calcipotriol (Psorcutan®-ointment containing 0.05 µg/g calcipotriol) to improve wound healing in dystrophic epidermolysis bullosa (DEB) - Topical calcipotriol in DEB
niversitätsklinik für Dermatologie, Paracelsus medizinische Privatuniversität Salzburg0 个研究点目标入组 15 人开始时间: 2016年6月28日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Signed Written Informed Consent
- •a) Subjects or legal guardians for minor children must have signed and dated an IRB/IEC approved written informed consent form in accordance with regulatory and institutional guidelines. This must be obtained before the performance of any protocol related procedures that are not part of normal subject care.
- •b) Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory testing, and other requirements of the study.
- •2. Target Population
- •a) Subjects with dystrophic epidermolysis bullosa (DEB) with a known mutation in the type VII collagen gene.
- •b) Subjects must have at least 2 wounds with a minimum size of 6 cm2 per wound.
- •3. Age and Reproductive Status
- •a) Children = 6 years, men and women.
- •b) Pregnant women are excluded from the study.
- •c) Women of childbearing potential (not surgically sterilized and between menarche and 1 year postmenopause) must agree to use appropriate medically accepted highly effective methods of contraception (failure rate of less than 1% per year). Medically accepted highly effective methods of contraception are: 3-monthly contraceptive injection, combined oral hormonal contraceptive pills containing ethinyl estradiol and progestogens, oral hormonal contraception with Cerazette®, vaginal ring (e.g. NuvaRing®), contraceptive transdermal patch (e.g. Evra®), contraceptive implant (e.g. Implanon®) and gestagen-containing intrauterine device.
- •Negative Serum ß-Human Chorionic Gonadotrophin (ß-HCG) pregnancy test at screening and crossover.
- •d) Surgically sterilized female patients with documentation of prior
- •hysterectomy, tubal ligation or complete bilateral oophorectomy and postmenopausal women do not require contraception.
- •e) Women must not be breastfeeding.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 6
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 9
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Medical History and Concurrent Diseases
- •a) Simultaneous participation in another clinical trial.
- •b) Any serious or uncontrolled medical disorder that, in the opinion of the investigator, may impair the ability of the subject to receive protocol therapy, or interfere with the interpretation of study results.
- •c) Subjects with a condition requiring systemic treatment with either corticosteroids (>10 mg daily prednisone equivalents) or other immunosuppressive medications or antibiotics within14 days of study drug administration.
- •d) Subjects with known severely impaired kidney-or liver function.
- •e) Subjects with known disorders of calcium metabolism.
- •2. Allergies and Adverse Drug Reactions
- •a) History of a severe hypersensitivity reaction to calcipotriol or other study drug components.
- •3. Sex and Reproductive Status
- •a) Women of childbearing potential who are pregnant or breastfeeding.
- •b) Women with a positive pregnancy test at screening or crossover.
研究者
相似试验
已完成
2 期
The effect of corticosteroids versus placebo on sleep quality in patients with advanced cancerACTRN12612000650897Mater Misericordiae Health Services Brisbane Ltd53
终止
4 期
Treatment of disordered blood pressure in spinal cord injuryHypotensionSpinal cord injuryACTRN12613001021763Austin Hospital4
进行中（未招募）
不适用
A placebo-controlled, double-blind, cross-over study with rupatadine 10 mg in 30 mosquito-bite allergic adult subjectsRupatadiini-antihistamiini hyttyspistoallergiassa - Rupatadiini-antihistamiini hyttyspistoallergiassamosquito-bite allergic adultsEUCTR2005-004422-50-FIJ.Uriach y Compania S.A.,30
已完成
不适用
A placebo-controlled, single-blind, crossover study to assess the effects of New Zealand pine bark extract (Enzogenol®) on glycaemic responses in healthy participantsDysglycaemiaGlycaemic controlDiet and Nutrition - Other diet and nutrition disordersMetabolic and Endocrine - DiabetesDiabetesACTRN12619001571167Massey University25
进行中（未招募）
1 期
A double-blind placebo-controlled cross-over study to determine if melatonin can improve the length of day time sleep in subjects with transient misalignment of the sleep-wake cycle as a result of working permanent night shifts.Transient misalignment of the sleep-wake cycle as a result of working night shifts (insomnia in night shift workers)EUCTR2005-000120-17-GBAlliance Pharmaceuticals Ltd60